CURTOLO, AMBROGIO
 Distribuzione geografica
Continente #
EU - Europa 338
NA - Nord America 227
AS - Asia 54
AF - Africa 6
SA - Sud America 1
Totale 626
Nazione #
IT - Italia 251
US - Stati Uniti d'America 221
SE - Svezia 30
SG - Singapore 27
IN - India 13
DE - Germania 12
BG - Bulgaria 9
FI - Finlandia 9
IE - Irlanda 9
CN - Cina 8
CA - Canada 5
TG - Togo 5
MY - Malesia 4
BE - Belgio 2
FR - Francia 2
GR - Grecia 2
LU - Lussemburgo 2
MK - Macedonia 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
CH - Svizzera 1
CL - Cile 1
GB - Regno Unito 1
HU - Ungheria 1
MX - Messico 1
PL - Polonia 1
TZ - Tanzania 1
Totale 626
Città #
Rome 71
Chandler 54
Milan 24
Fairfield 18
Houston 11
Singapore 11
Ashburn 10
Sofia 9
Helsinki 8
New York 8
Princeton 8
San Paolo di Civitate 8
Woodbridge 8
Dublin 7
Naples 7
Lawrence 6
Pisa 6
Seattle 6
Lomé 5
San Diego 5
Ann Arbor 4
Ascoli Piceno 4
Florence 4
Induno Olona 4
Millbury 4
Padova 4
Wilmington 4
Barrie 3
Biancavilla 3
Boardman 3
Boston 3
Bremen 3
Cambridge 3
Los Angeles 3
San Cesareo 3
San Giovanni Lupatoto 3
Albano Laziale 2
Andover 2
Athens 2
Bari 2
Bologna 2
Brussels 2
Bühl 2
Chennai 2
Chicago 2
Foggia 2
Fuzhou 2
Hangzhou 2
Lingolsheim 2
Montalto Uffugo 2
Norwalk 2
Piacenza 2
Pofi 2
Poggio Renatico 2
Porto 2
Savignano sul Panaro 2
Toronto 2
Varese 2
Alessandria 1
Altofonte 1
Beijing 1
Bern 1
Boscoreale 1
Budapest 1
Clifton 1
Edinburgh 1
Fiuggi 1
Fremont 1
Gazzo 1
Gdynia 1
Genoa 1
Gozzano 1
Guangzhou 1
Lappeenranta 1
Lecco 1
Livorno 1
Lucca 1
Mannheim 1
Melzo 1
Mexico City 1
Mysore 1
Nanjing 1
Novara 1
Perugia 1
Reggio Emilia 1
Ronciglione 1
Sabaudia 1
Sacramento 1
San Mateo 1
Santa Maria 1
Scarperia e San Piero 1
Stockholm 1
Turin 1
Venafro 1
Verona 1
Totale 426
Nome #
Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem. A case report 120
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 100
Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside 86
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 66
Curb-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with sars-cov-2 pneumonia 54
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature 48
Are Follow-Up Blood Cultures useful in the antimicrobial management of gram negative bacteremia? A reappraisal of their role based on current knowledge 44
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization 40
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 36
Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared 32
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae. Results from a multicentre retrospective study 23
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study 18
New antimicrobials and new therapy strategies for endocarditis. Weapons that should be defended 5
null 4
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study 2
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study 1
Totale 679
Categoria #
all - tutte 2.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 1 4 24 5 6 11
2021/2022156 12 22 6 5 10 6 10 8 15 2 38 22
2022/2023235 22 37 31 30 27 13 1 22 28 6 11 7
2023/2024231 8 12 28 18 19 32 8 21 8 39 25 13
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 679